19th Congress of the European Hematology Association (EHA)
June 12, 2014 ‐ June 15, 2014 in Milan, Italy
Cellectis to present new data update on its allogeneic CAR T cell therapeutics at the 19th Congress of the European Hematology Association (EHA)
Dr. Julianne Smith, PhD, VP CART Development at Cellectis and Dr. Roman Galetto, PhD, Project Leader, will be attending the 19th Congress of the European Hematology Association in Milan, Italy from June 12th to 15th, 2014.
Roman Galetto will present a study entitled: MULTIPLEX GENOME EDITING OF TCRALPHA/CD52 GENES AS A PLATFORM FOR “OFF THE SHELF” ADOPTIVE T-CELL IMMUNOTHERAPIES on the late breaker session to be held on Saturday, June 14th at 1:30pm in the Auditorium (NW – Level 3).